WEDNESDAY, Jan. 23 (HealthDay News) -- Exjade (deferasirox) has been approved by the U.S. Food and Drug Administration to remove excess iron in the blood among people with a genetic blood disorder called non-transfusion-dependent thalassemia (NTDT).
Too much iron in the blood can damage vital organs, the agency said Wednesday in a news release.
Thalassemia typically leads to the production of fewer red blood cells and less hemoglobin, a protein that carries oxygen throughout the body. NTDT is a milder form of thalassemia that unlike other forms, does not require frequent blood transfusions. Thalassemia affects about 1,000 people in the United States, the FDA said.
The FDA previously approved Exjade to treat chronic iron overload among people who require blood transfusions.
The drug is produced by Novartis, East Hanover, N.J.
The U.S. National Heart Lung and Blood Institute has more about thalassemia.
be well, feel better
The right nutrition and three squares a day will help you lose fat fast!
Don't undermine the efforts of your loved ones who are trying to slim down.
If you've opened a SkyMall lately, you know there are dozens of products out there designed to clean indoor air. But do they actually work? We asked the experts what you really need.
A review of the eight biggest headlines of the year
From sleeping in to using vodka in place of hand sanitizer, check out the surprising stay-well secrets that real experts swear by.
In the dregs of winter it's easy to get down. So we reached out to Keri Glassman, nutritionist and author of The New You and Improved Diet, for some tips on how to keep those blues at bay.
Eat more and get slimmer (we promise!) by shopping from this list of truly satisfying, cravings-curbing foods.
How to fight colds, heartburn, joint pain, allergies, and other ailments by choosing the right food.